Nature Biotechnology
Volume 40 Issue 4, April 2022
https://www.nature.com/nbt/volumes/40/issues/4

Editorial | 04 April 2022
Licensing for profit and for good
The Broad Institute’s enlightened licensing approach to CRISPR–Cas9 intellectual property stands out in the otherwise regrettable spat for patent rights over the foundational technology.